SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001557142-19-000052
Filing Date
2019-08-05
Accepted
2019-08-05 16:28:48
Documents
82
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kdmn-20190630x10q.htm 10-Q 1644893
2 EX-3.1 kdmn-20190630xex3_1.htm EX-3.1 51000
3 EX-31.1 kdmn-20190630xex31_1.htm EX-31.1 20228
4 EX-31.2 kdmn-20190630xex31_2.htm EX-31.2 20327
5 EX-32.1 kdmn-20190630xex32_1.htm EX-32.1 10305
6 EX-32.2 kdmn-20190630xex32_2.htm EX-32.2 10143
  Complete submission text file 0001557142-19-000052.txt   7241665

Data Files

Seq Description Document Type Size
7 EX-101.INS kdmn-20190630.xml EX-101.INS 1533529
8 EX-101.SCH kdmn-20190630.xsd EX-101.SCH 52833
9 EX-101.CAL kdmn-20190630_cal.xml EX-101.CAL 73898
10 EX-101.DEF kdmn-20190630_def.xml EX-101.DEF 225079
11 EX-101.LAB kdmn-20190630_lab.xml EX-101.LAB 443846
12 EX-101.PRE kdmn-20190630_pre.xml EX-101.PRE 393625
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37841 | Film No.: 19999029
SIC: 2834 Pharmaceutical Preparations